Stocks in news: Pfizer, Rel Power, RIL

Stocks in news:

• Board meetings:
  AstraZeneca Pharma results for year ended Dec
  Goldiam International on buy back
  Pfizer results for year ended Nov
• Ex-split:
  PTL from Rs 10 to Rs 2
  Walchandnagar Ind from Rs 10 to Rs 2
• Ex-bonus:
  Walchandnagar Ind at 1:1
• Ex-event:
  Sical Logistics; base price Rs 257, circuit filter 5%
• Reliance Power
  Board approved bonus of 3 shares for every 5 shares
  Promoter Stake: 84.8%, Public Stake: 15.2%
  Reliance Energy Stake post bonus issue remains at 45%; ADA Grp to hold 40%
  ADA to compensate REL by making up 2.6% from his own holdings
• HDFC Bank, CBoP
  HDFC Bank, CBoP Boards Give In Principle Approval For Merger
  HDFC Bk, CBoP Board Meet currently on to Consider Swap Ratio
  Boards To Meet On Feb 28 To Consider Draft Scheme Of Amalgamation
  CBoP Likely To Be Valued At Close To Rs 64/share
• RIL eyes retail JV with Marks & Spencer, deal likely to be clinched in 3 weeks - ET
• TCS and Cognizant in race for Deutsche Bank unit T- System, sale likely this week - DNA
• Tata Motors mandates banks to raise $2.5bn, large chunk to be used for Jaguar and Land Rover - ET
• HPCL, BPCL and IOC have initiated document work to buy 15-35% stake in two of the largest Brazilian integrated ethanol players - TOI
• Bajaj Hindustan Rs 150 cr stock seized for non-payment of last seasons sugar cane prices to farmers; dues owned were Rs 300 cr - BS
• Kishore Biyani pulls out of Dish TV deal, Zee may move to court - ET
• IT firms goe slow on hiring from IITs, slowdown looms large - BS
• Excise sops for 6 Re-hit sectors, extension of Interest waiver too approved- ET
• Jetlite set to clock a turnover of $460m for year ended March 2008, however it is yet to breakeven - BS
• Celebrity Fashions to sell Chennai Facility - BL
• Steel prices hike likely again - BS
• IOB to pick up 10% stake in JM Financials ARC
• Idea, Spice cry foul as Videocon heads spectrum queue - ET
• L&T, IRB among 5 to bag Rs 11k cr road projects - DNA
• REC closed on Friday, subscribed 27.9x, QIB 39.3x, HNI 27.1x, Retail 7.7x